Xiaomi’s ‘Tesla killer’, Beijing-Ottawa tariff deal promising for China market: 7 EV reads


We have put together stories from our coverage on electric and new energy vehicles from the past two weeks to help you stay informed. If you would like to see more of our reporting, please consider subscribing.

1. China’s flying car makers aim for deliveries this year as passenger use nears

China could see its first flying car begin carrying paying passengers in 2026, as government backing and a growing pipeline of electric vertical take-off and landing (eVTOL) vehicle makers push the country’s “low-altitude economy” closer to commercial reality.

2. Xiaomi’s SU7 becomes China’s first Tesla killer, outselling the Model 3

After five years of playing catch-up, China has produced a worthy “Tesla killer”, a massive achievement for the country’s premium electric vehicle (EV) makers that is set to stoke national pride.

3. Beijing-Ottawa deal reinforces China’s dominance in EV industry, analysts say

Canadian Prime Minister Mark Carney met Chinese President Xi Jinping in Beijing on January 16, where the pair announced a new strategic partnership that will open Canada up to Chinese electric vehicles. Photo: Reuters
Canadian Prime Minister Mark Carney met Chinese President Xi Jinping in Beijing on January 16, where the pair announced a new strategic partnership that will open Canada up to Chinese electric vehicles. Photo: Reuters

Beijing and Ottawa reached a “landmark” trade agreement last month, slashing tariffs on Chinese electric vehicles, in a move analysts said further cements China’s dominance and suggests the US decline in the global EV market.

  • Related Posts

    Chinese power line projects seek private capital in sign of infrastructure shift

    In the latest sign of China’s push to channel private capital into infrastructure, several local governments have begun actively seeking private investors for two major ultra-high-voltage power line projects –…

    Continue reading
    China charges former AstraZeneca executive – what it means for global pharmaceutical firms

    AstraZeneca’s former China head has been formally charged with medical insurance fraud, illegal trading and unlawful collection of personal information, more than a year after he first came under investigation…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *